These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24741192)

  • 1. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice.
    Bhatt S; Radhakrishnan M; Jindal A; Devadoss T; Dhar AK
    Indian J Pharmacol; 2014; 46(2):191-6. PubMed ID: 24741192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    Pharmacol Rep; 2014 Oct; 66(5):804-10. PubMed ID: 25149984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    Pharmacol Biochem Behav; 2014 Jul; 122():234-9. PubMed ID: 24769308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of (4a) a novel 5-HT3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery.
    Kurhe Y; Mahesh R; Gupta D; Thangaraj D
    J Basic Clin Physiol Pharmacol; 2015 Jan; 26(1):25-33. PubMed ID: 24706431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    J Basic Clin Physiol Pharmacol; 2017 Mar; 28(2):101-106. PubMed ID: 27664773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.
    Kurhe Y; Radhakrishnan M; Gupta D; Devadoss T
    J Pharm Pharmacol; 2014 Jan; 66(1):122-32. PubMed ID: 24180368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
    Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
    Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences.
    Kumar B; Kuhad A; Chopra K
    Psychopharmacology (Berl); 2011 Apr; 214(4):819-28. PubMed ID: 21103863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice.
    Gupta D; Radhakrishnan M; Kurhe Y
    Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage.
    Jindal A; Mahesh R; Bhatt S
    Pharmacol Biochem Behav; 2013 Apr; 105():63-70. PubMed ID: 23384434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: an approach based on behavioral and biochemical investigations.
    Kurhe Y; Mahesh R; Gupta D; Devadoss T
    Eur J Pharmacol; 2014 Oct; 740():611-8. PubMed ID: 24973694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety.
    Bhatt S; Mahesh R; Devadoss T; Jindal AK
    Indian J Pharmacol; 2013; 45(3):248-51. PubMed ID: 23833367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
    Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
    Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice.
    Thakare VN; Patil RR; Oswal RJ; Dhakane VD; Aswar MK; Patel BM
    J Psychopharmacol; 2018 Feb; 32(2):223-235. PubMed ID: 29215318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic and antidepressant effects of Ziziphus mucronata hydromethanolic extract in male rats exposed to unpredictable chronic mild stress: Possible mechanisms of actions.
    Keugong Wado E; Kubicki M; Ngatanko AHH; Léa Blondelle KD; Jorelle Linda D; Roland RN; Balbine K; Lamshoeft M; Assongalem AE; Foyet HS
    J Ethnopharmacol; 2020 Oct; 260():112987. PubMed ID: 32446929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    J Basic Clin Physiol Pharmacol; 2017 Mar; 28(2):93-100. PubMed ID: 27662644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.
    Kurhe Y; Mahesh R; Devadoss T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):74-9. PubMed ID: 25446100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: an investigation in behaviour-based rodent models of depression.
    Mahesh R; Kumar B; Jindal A; Bhatt S; Devadoss T; Pandey DK
    Indian J Pharmacol; 2012; 44(5):560-5. PubMed ID: 23112413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocatechuic acid attenuates chronic unpredictable mild stress induced-behavioral and biochemical alterations in mice.
    Thakare VN; Lakade SH; Mahajan MP; Kulkarni YP; Dhakane VD; Harde MT; Patel BM
    Eur J Pharmacol; 2021 May; 898():173992. PubMed ID: 33675783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.